| Mr Jashu Patel, MD | |
|
205 Page Ave, Jackson, MI 49201-2462 | |
| (517) 787-3577 | |
| (517) 787-4280 |
| Full Name | Mr Jashu Patel |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 42 Years |
| Location | 205 Page Ave, Jackson, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366408692 | NPI | - | NPPES |
| 1645805 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | JP046099 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Henry Ford Allegiance Health | Jackson, MI | Hospital |
| Hillsdale Hospital | Hillsdale, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| W.a. Foote Memorial Hospital, Inc. | 0244136067 | 435 |
| Rajendra Mehta, Md, Pc | 3577973833 | 2 |
News Archive
A new study led by clinician-researchers at Beth Israel Deaconess Medical Center has found that hospital-led interventions over a seven-year period were associated with a significant reduction in the hospital's Cesarean delivery rate.
Is it better to tell people about the harms of certain health decisions or about the benefits of positive health related decisions? Studies that delve into this very question have differing results, however, a new paper just published by Cornell Food & Brand Lab in Nutrition Reviews, finds that the type of health messaging that is most effective might vary depending on certain characteristics of the target audience.
BioMarin Pharmaceutical Inc. announced today that the first subject has initiated treatment in a Phase 3b study (PKU-016) to evaluate the effects of Kuvan (sapropterin dihydrochloride) on neuropsychiatric symptoms in subjects with phenylketonuria (PKU). BioMarin expects to report results in the first half of 2012.
The NIH has announced it will fund a nationwide preclinical trial focusing on robust testing of new treatments for acute ischemic stroke.
Most people think the development of the heart only happens in the womb, however the days and weeks following birth are full of cellular changes that play a role in the structure and function of the heart. Using mouse models, researchers at Baylor College of Medicine have now been able to categorize the alternative splicing (the process in which genes code proteins, determining their role) that takes place during these changes and what mechanisms they affect.
› Verified 9 days ago
| Entity Name | W.a. Foote Memorial Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760437826 PECOS PAC ID: 0244136067 Enrollment ID: O20031212000691 |
News Archive
A new study led by clinician-researchers at Beth Israel Deaconess Medical Center has found that hospital-led interventions over a seven-year period were associated with a significant reduction in the hospital's Cesarean delivery rate.
Is it better to tell people about the harms of certain health decisions or about the benefits of positive health related decisions? Studies that delve into this very question have differing results, however, a new paper just published by Cornell Food & Brand Lab in Nutrition Reviews, finds that the type of health messaging that is most effective might vary depending on certain characteristics of the target audience.
BioMarin Pharmaceutical Inc. announced today that the first subject has initiated treatment in a Phase 3b study (PKU-016) to evaluate the effects of Kuvan (sapropterin dihydrochloride) on neuropsychiatric symptoms in subjects with phenylketonuria (PKU). BioMarin expects to report results in the first half of 2012.
The NIH has announced it will fund a nationwide preclinical trial focusing on robust testing of new treatments for acute ischemic stroke.
Most people think the development of the heart only happens in the womb, however the days and weeks following birth are full of cellular changes that play a role in the structure and function of the heart. Using mouse models, researchers at Baylor College of Medicine have now been able to categorize the alternative splicing (the process in which genes code proteins, determining their role) that takes place during these changes and what mechanisms they affect.
› Verified 9 days ago
| Entity Name | W.a. Foote Memorial Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831123728 PECOS PAC ID: 0244136067 Enrollment ID: O20031212000875 |
News Archive
A new study led by clinician-researchers at Beth Israel Deaconess Medical Center has found that hospital-led interventions over a seven-year period were associated with a significant reduction in the hospital's Cesarean delivery rate.
Is it better to tell people about the harms of certain health decisions or about the benefits of positive health related decisions? Studies that delve into this very question have differing results, however, a new paper just published by Cornell Food & Brand Lab in Nutrition Reviews, finds that the type of health messaging that is most effective might vary depending on certain characteristics of the target audience.
BioMarin Pharmaceutical Inc. announced today that the first subject has initiated treatment in a Phase 3b study (PKU-016) to evaluate the effects of Kuvan (sapropterin dihydrochloride) on neuropsychiatric symptoms in subjects with phenylketonuria (PKU). BioMarin expects to report results in the first half of 2012.
The NIH has announced it will fund a nationwide preclinical trial focusing on robust testing of new treatments for acute ischemic stroke.
Most people think the development of the heart only happens in the womb, however the days and weeks following birth are full of cellular changes that play a role in the structure and function of the heart. Using mouse models, researchers at Baylor College of Medicine have now been able to categorize the alternative splicing (the process in which genes code proteins, determining their role) that takes place during these changes and what mechanisms they affect.
› Verified 9 days ago
| Entity Name | W.a. Foote Memorial Hospital, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629000708 PECOS PAC ID: 0244136067 Enrollment ID: O20040612000395 |
News Archive
A new study led by clinician-researchers at Beth Israel Deaconess Medical Center has found that hospital-led interventions over a seven-year period were associated with a significant reduction in the hospital's Cesarean delivery rate.
Is it better to tell people about the harms of certain health decisions or about the benefits of positive health related decisions? Studies that delve into this very question have differing results, however, a new paper just published by Cornell Food & Brand Lab in Nutrition Reviews, finds that the type of health messaging that is most effective might vary depending on certain characteristics of the target audience.
BioMarin Pharmaceutical Inc. announced today that the first subject has initiated treatment in a Phase 3b study (PKU-016) to evaluate the effects of Kuvan (sapropterin dihydrochloride) on neuropsychiatric symptoms in subjects with phenylketonuria (PKU). BioMarin expects to report results in the first half of 2012.
The NIH has announced it will fund a nationwide preclinical trial focusing on robust testing of new treatments for acute ischemic stroke.
Most people think the development of the heart only happens in the womb, however the days and weeks following birth are full of cellular changes that play a role in the structure and function of the heart. Using mouse models, researchers at Baylor College of Medicine have now been able to categorize the alternative splicing (the process in which genes code proteins, determining their role) that takes place during these changes and what mechanisms they affect.
› Verified 9 days ago
| Entity Name | Jackson Cardiology & Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841200722 PECOS PAC ID: 9830168830 Enrollment ID: O20040927000966 |
News Archive
A new study led by clinician-researchers at Beth Israel Deaconess Medical Center has found that hospital-led interventions over a seven-year period were associated with a significant reduction in the hospital's Cesarean delivery rate.
Is it better to tell people about the harms of certain health decisions or about the benefits of positive health related decisions? Studies that delve into this very question have differing results, however, a new paper just published by Cornell Food & Brand Lab in Nutrition Reviews, finds that the type of health messaging that is most effective might vary depending on certain characteristics of the target audience.
BioMarin Pharmaceutical Inc. announced today that the first subject has initiated treatment in a Phase 3b study (PKU-016) to evaluate the effects of Kuvan (sapropterin dihydrochloride) on neuropsychiatric symptoms in subjects with phenylketonuria (PKU). BioMarin expects to report results in the first half of 2012.
The NIH has announced it will fund a nationwide preclinical trial focusing on robust testing of new treatments for acute ischemic stroke.
Most people think the development of the heart only happens in the womb, however the days and weeks following birth are full of cellular changes that play a role in the structure and function of the heart. Using mouse models, researchers at Baylor College of Medicine have now been able to categorize the alternative splicing (the process in which genes code proteins, determining their role) that takes place during these changes and what mechanisms they affect.
› Verified 9 days ago
| Entity Name | Rajendra Mehta, Md, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477168607 PECOS PAC ID: 3577973833 Enrollment ID: O20201028000965 |
News Archive
A new study led by clinician-researchers at Beth Israel Deaconess Medical Center has found that hospital-led interventions over a seven-year period were associated with a significant reduction in the hospital's Cesarean delivery rate.
Is it better to tell people about the harms of certain health decisions or about the benefits of positive health related decisions? Studies that delve into this very question have differing results, however, a new paper just published by Cornell Food & Brand Lab in Nutrition Reviews, finds that the type of health messaging that is most effective might vary depending on certain characteristics of the target audience.
BioMarin Pharmaceutical Inc. announced today that the first subject has initiated treatment in a Phase 3b study (PKU-016) to evaluate the effects of Kuvan (sapropterin dihydrochloride) on neuropsychiatric symptoms in subjects with phenylketonuria (PKU). BioMarin expects to report results in the first half of 2012.
The NIH has announced it will fund a nationwide preclinical trial focusing on robust testing of new treatments for acute ischemic stroke.
Most people think the development of the heart only happens in the womb, however the days and weeks following birth are full of cellular changes that play a role in the structure and function of the heart. Using mouse models, researchers at Baylor College of Medicine have now been able to categorize the alternative splicing (the process in which genes code proteins, determining their role) that takes place during these changes and what mechanisms they affect.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Jashu Patel, MD 6076 Browns Lake Rd, Jackson, MI 49203-5609 Ph: () - | Mr Jashu Patel, MD 205 Page Ave, Jackson, MI 49201-2462 Ph: (517) 787-3577 |
News Archive
A new study led by clinician-researchers at Beth Israel Deaconess Medical Center has found that hospital-led interventions over a seven-year period were associated with a significant reduction in the hospital's Cesarean delivery rate.
Is it better to tell people about the harms of certain health decisions or about the benefits of positive health related decisions? Studies that delve into this very question have differing results, however, a new paper just published by Cornell Food & Brand Lab in Nutrition Reviews, finds that the type of health messaging that is most effective might vary depending on certain characteristics of the target audience.
BioMarin Pharmaceutical Inc. announced today that the first subject has initiated treatment in a Phase 3b study (PKU-016) to evaluate the effects of Kuvan (sapropterin dihydrochloride) on neuropsychiatric symptoms in subjects with phenylketonuria (PKU). BioMarin expects to report results in the first half of 2012.
The NIH has announced it will fund a nationwide preclinical trial focusing on robust testing of new treatments for acute ischemic stroke.
Most people think the development of the heart only happens in the womb, however the days and weeks following birth are full of cellular changes that play a role in the structure and function of the heart. Using mouse models, researchers at Baylor College of Medicine have now been able to categorize the alternative splicing (the process in which genes code proteins, determining their role) that takes place during these changes and what mechanisms they affect.
› Verified 9 days ago
James Brown Chauncey Iii, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 205 N East Ave, Jackson, MI 49201 Phone: 517-788-4800 | |
Mrs. Bharti Sachdev, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 766 W Michigan Ave, Jackson, MI 49201 Phone: 517-784-9910 Fax: 517-787-4404 | |
Dr. Gregory A Naylor, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 505 N Jackson St, Jackson, MI 49201 Phone: 517-748-5500 Fax: 517-780-9286 | |
Rolando Manalo Beredo, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 426 N Jackson St, Jackson, MI 49201 Phone: 517-788-6336 Fax: 517-788-9035 | |
Essam Y. Tellawi, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 205 N East Ave, Jackson, MI 49201 Phone: 517-205-4800 | |
Dr. Fadi Alali, M.D Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 744 W Michigan Ave Ste 201, Jackson, MI 49201 Phone: 517-205-7618 Fax: 517-205-7639 | |
Dr. Abdulbaset M. Salim, MD, MPH Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 205 N East Ave, Jackson, MI 49201 Phone: 517-205-1328 |